The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis
The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis
Not yet recruiting · NCT06773221 · Registry updated 2025-01-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis | Compensated Liver Cirrhosis; Metabolic Dysfunction Associated Fatty Liver Disease | Not yet recruiting | Not applicable | 2025-01-15 | NCT06773221 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Ditan Hospital | 26 |
| Beijing Friendship Hospital | 120 |
| Beijing YouAn Hospital | 20 |
| Peking University People's Hospital | 269 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Ditan Hospital, Capital Medical University | Beijing | China | 1 |
| Beijing Friendship Hospital, Capital Medical University | Beijing | China | 2 |
| Beijing Youan Hospital, Capital Medical University | Beijing | China | 1 |
| Peking University People's Hospital | Beijing | China | 5 |